Tirzepatide near Westchester —
dual GIP/GLP-1, maximum results.
Westchester (33155) residents drive just 5 minutes to our Sweetwater clinic at 917 SW 87th Ave. Physician-supervised Tirzepatide programs from $399/month. The dual agonist that produces up to 20.9% weight loss.
Directions from Westchester (33155)
5-7 min drive, no highway
Head west on SW 8th Street (Calle Ocho) or Coral Way (SW 24th St) toward SW 87th Ave. Turn north on SW 87th Ave. The clinic is at 917 SW 87th Ave, Sweetwater FL 33174. Ample parking on-site.
Get DirectionsWhy Tirzepatide outperforms single-mechanism GLP-1s
Tirzepatide is a dual GIP/GLP-1 receptor agonist. While Semaglutide activates only GLP-1 receptors, Tirzepatide activates both GLP-1 and GIP receptors — producing synergistic effects on appetite, metabolism, and insulin sensitivity.
Enhanced appetite suppression
Dual receptor activation targets multiple brain pathways that control hunger. Patients report dramatically stronger satiety signals and reduced food noise compared to single-mechanism medications.
Superior gastric emptying
The GIP component enhances the GLP-1 effect on stomach emptying, extending fullness even longer. Less hunger means easier caloric deficit without willpower battles.
Improved insulin response
GIP and GLP-1 work synergistically to improve glucose control and insulin sensitivity. Ideal for patients with prediabetes, metabolic syndrome, or insulin resistance.
Enhanced fat metabolism
The dual mechanism promotes greater fat oxidation and metabolic rate increases. Clinical trials show approximately 6% greater weight loss than GLP-1 agonists alone.
Westchester Area Pricing
Tirzepatide 2.5-5mg/week, physician evaluation, all supplies included
Tirzepatide 7.5-10mg/week, ongoing dose optimization, monthly check-ins
Tirzepatide 12.5-15mg/week, maximum efficacy dosing, priority support
Weekly B12 + lipotropic MIC injection for energy and fat metabolism
Free intake consultation, no hidden fees
The most effective weight loss medication ever studied
avg. body weight loss (SURMOUNT-1, 72 weeks)
Tirzepatide 15mg
of patients lost 5%+ body weight
SURMOUNT-1 trial
week landmark trial with sustained results
SURMOUNT-1 clinical trial
when most patients see first results
Based on clinical onset data
Tirzepatide vs Semaglutide: Clinical Comparison
Real results from your neighbors.
"I tried Semaglutide first and lost 15 lbs, but Tirzepatide took me to the next level. Down 38 lbs total. The dual mechanism really does make a difference. The clinic is so close to Westchester I can go during my lunch break."
Carmen R.
Westchester FL 33155 · Tirzepatide
"As a type 2 diabetic, Tirzepatide has been life-changing. My A1C dropped from 8.2 to 6.1 and I have lost 44 lbs. The dual GIP/GLP-1 action is incredible. Best medical decision I have ever made."
Alejandro M.
SW 87th Ave corridor · Tirzepatide
"I was skeptical about switching from Semaglutide to Tirzepatide, but my doctor explained the science and I am so glad I did. The appetite suppression is stronger and I have way more energy."
Diana F.
Westchester Miami · Tirzepatide
Common questions from Westchester patients.
Our clinic is at 917 SW 87th Ave, Sweetwater FL 33174, just 5-7 minutes from Westchester via SW 8th Street or Coral Way. No highway required. We serve hundreds of Westchester patients with physician-supervised Tirzepatide, Semaglutide, and B12 lipotropic programs.
Tirzepatide programs start at $399/month. This includes the medication, physician evaluation, dosing adjustments, and ongoing support. Fully transparent pricing with no hidden fees. Same active ingredient as Mounjaro and Zepbound at a fraction of brand-name cost.
Tirzepatide is a dual GIP/GLP-1 receptor agonist that activates both hormone receptors, while Semaglutide only activates GLP-1. This dual mechanism produces greater average weight loss: approximately 20.9% body weight with Tirzepatide vs 14.9% with Semaglutide at maximum doses.
Most patients begin noticing reduced appetite within 1-2 weeks. Measurable weight loss typically appears at weeks 4-8. The SURMOUNT trials showed an average 20.9% body weight reduction at 72 weeks. Many Westchester patients exceed clinical averages with consistent use.
Tirzepatide is the identical active molecule in both Mounjaro (diabetes) and Zepbound (weight management). Our compounded Tirzepatide uses the same active ingredient at physician-calibrated doses. The key differences: significantly lower cost, flexible dosing, and a real in-person clinic.
Yes, and we highly recommend it. B12 + lipotropic injections are the ideal complement to Tirzepatide. They counteract the fatigue common in early dual agonist therapy and accelerate fat metabolism. Most Westchester patients combine weekly B12 shots with their monthly Tirzepatide program.
5 minutes from Westchester
917 SW 87th Ave, Sweetwater FL 33174 — No highway required from 33155
Start your Tirzepatide journey today.
Physician-supervised dual GIP/GLP-1 Tirzepatide programs from $399/month. Real doctors. Real clinic. Just 5 minutes from Westchester.